Evidence map›Paper›PMID 37231606›Full record

ArticleThe international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease2023

Higher yield using an event-based vs. door-to-door approach for active case-finding for TB.

A Malhotra, J Mukiibi, P J Kitonsa, A Nalutaaya, C E Kamoga, K O Robsky, D Isooba, M Nantale, O Nakasolya, F Kayondo and 5 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

A MalhotraDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
J MukiibiUganda Tuberculosis Implementation Research Consortium, Makerere University, Kampala, Uganda.
P J KitonsaUganda Tuberculosis Implementation Research Consortium, Makerere University, Kampala, Uganda.
A NalutaayaUganda Tuberculosis Implementation Research Consortium, Makerere University, Kampala, Uganda.
C E KamogaUganda Tuberculosis Implementation Research Consortium, Makerere University, Kampala, Uganda.
K O RobskyDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA, Uganda Tuberculosis Implementation Research Consortium, Makerere University, Kampala, Uganda.
D IsoobaUganda Tuberculosis Implementation Research Consortium, Makerere University, Kampala, Uganda.
M NantaleUganda Tuberculosis Implementation Research Consortium, Makerere University, Kampala, Uganda.
O NakasolyaUganda Tuberculosis Implementation Research Consortium, Makerere University, Kampala, Uganda.
F KayondoUganda Tuberculosis Implementation Research Consortium, Makerere University, Kampala, Uganda.
M MukiibiUganda Tuberculosis Implementation Research Consortium, Makerere University, Kampala, Uganda.
R KiyongaUganda Tuberculosis Implementation Research Consortium, Makerere University, Kampala, Uganda.
D W DowdyDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA, Uganda Tuberculosis Implementation Research Consortium, Makerere University, Kampala, Uganda.
A KatambaUganda Tuberculosis Implementation Research Consortium, Makerere University, Kampala, Uganda, Department of Medicine, Clinical Epidemiology and Biostatistics Unit, College of Health Sciences, Makerere University, Kampala, Uganda.
E A KendallUganda Tuberculosis Implementation Research Consortium, Makerere University, Kampala, Uganda, Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Funding

Hotspot versus clinic-based active case finding for TB in Uganda: A pragmatic randomized trialR01HL138728 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI David Wesley Dowdy, Emily A Kendall · 2017 to 2026
$5.4M
Who are the Ultra-positive, culture-negative? Understanding the trajectories of individuals in Uganda with trace M. tuberculosis nucleic acid in sputumR01HL153611 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI KENDALL, EMILY A · 2020 to 2024
$3.2M
NHLBI NIH HHS R01 HL138728NHLBI NIH HHS R01 HL153611
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

TuberculosisTuberculosis, PulmonaryHumansMass Screening

Identifiers

PMID37231606
PMCPMC10228757

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.